Echelon Wealth Partners Thinks Indiva’s Stock is Going to Recover
April 22 2022 - 05:35PM
TipRanks
In a report issued on April 20, Andrew Semple from Echelon Wealth
Partners maintained a Buy rating on Indiva (NDVAF – Research
Report). The company's shares closed last Friday at $0.20, close to
its 52-week low of $0.19. According to TipRanks.com, Semple is a
4-star analyst with an average return of 12.8% and a 24.4% success
rate. Semple covers the Basic Materials sector, focusing on stocks
such as Ascend Wellness Holdings LLC, Green Thumb Industries, and
Trulieve Cannabis. The word on The Street in general, suggests a
Moderate Buy analyst consensus rating for Indiva. See the top
stocks recommended by analysts >> Indiva's market cap is
currently $25.
https://www.tipranks.com/news/blurbs/echelon-wealth-partners-thinks-indivas-stock-is-going-to-recover?utm_source=advfn.com&utm_medium=referral
Indiva (PK) (USOTC:NDVAF)
Historical Stock Chart
From May 2023 to Jun 2023
Indiva (PK) (USOTC:NDVAF)
Historical Stock Chart
From Jun 2022 to Jun 2023